These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534 [TBL] [Abstract][Full Text] [Related]
63. [Localized scleroderma: a retrospective study about 92 cases]. El Fékih N; Réjaibi I; Kamoun H; Zéglaoui F; Fazaa B; Kharfi M; Kamoun MR Tunis Med; 2009 Sep; 87(9):573-8. PubMed ID: 20180376 [TBL] [Abstract][Full Text] [Related]
64. MRI findings in deep and generalized morphea (localized scleroderma). Horger M; Fierlbeck G; Kuemmerle-Deschner J; Tzaribachev N; Wehrmann M; Claussen CD; Fritz J AJR Am J Roentgenol; 2008 Jan; 190(1):32-9. PubMed ID: 18094291 [TBL] [Abstract][Full Text] [Related]
67. A case of lipodystrophia centrifugalis abdominalis infantilis with morphea. Ikoma A; Tanaka T; Miyachi Y J Dermatol; 1999 Sep; 26(9):603-7. PubMed ID: 10535256 [TBL] [Abstract][Full Text] [Related]
68. Histopathologic Spectrum of Morphea. Chiu YE; Abban CY; Konicke K; Segura A; Sokumbi O Am J Dermatopathol; 2021 Jan; 43(1):1-8. PubMed ID: 33337624 [TBL] [Abstract][Full Text] [Related]
69. Disabling pansclerotic morphea of childhood with extracutaneous manifestations. Kura MM; Jindal SR Indian J Dermatol; 2013 Mar; 58(2):159. PubMed ID: 23716826 [TBL] [Abstract][Full Text] [Related]
70. Responsiveness to Change of the Morphea Activity Measure in Pediatric Patients. García-Romero MT; Brandling-Bennett HA; Pope E; Sibbald C; Medina-Vera I; Elizalde-Jiménez IG; Chiu YE JAMA Dermatol; 2024 Jul; 160(7):736-740. PubMed ID: 38837147 [TBL] [Abstract][Full Text] [Related]
71. Correlates of self-reported quality of life in adults and children with morphea. Das S; Bernstein I; Jacobe H J Am Acad Dermatol; 2014 May; 70(5):904-10. PubMed ID: 24534655 [TBL] [Abstract][Full Text] [Related]
73. Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease. Sink JR; Chiu YE Pediatr Dermatol; 2021 Sep; 38(5):1020-1031. PubMed ID: 34272748 [TBL] [Abstract][Full Text] [Related]
74. Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face. Careta MF; Leite Cda C; Cresta F; Albino J; Tsunami M; Romiti R Autoimmun Rev; 2013 Sep; 12(11):1064-9. PubMed ID: 23791631 [TBL] [Abstract][Full Text] [Related]
75. Localized forms of scleroderma, including morphea, linear scleroderma, and eosinophilic fasciitis. Nelson AM Curr Opin Rheumatol; 1996 Sep; 8(5):473-6. PubMed ID: 8941452 [TBL] [Abstract][Full Text] [Related]
76. A retrospective study: Impact of consensus treatment plans on systemic therapy of pediatric morphea. Do N; Ringold S; Sullivan E; Brandling-Bennett H Pediatr Dermatol; 2020 Mar; 37(2):278-283. PubMed ID: 31967352 [TBL] [Abstract][Full Text] [Related]
77. Morphea: a practical review of its diagnosis, classification and treatment. Rodríguez-Salgado P; García-Romero MT Gac Med Mex; 2019; 155(5):483-491. PubMed ID: 32091025 [TBL] [Abstract][Full Text] [Related]
78. Headaches as a presenting symptom of linear morphea en coup de sabre. Polcari I; Moon A; Mathes EF; Gilmore ES; Paller AS Pediatrics; 2014 Dec; 134(6):e1715-9. PubMed ID: 25404727 [TBL] [Abstract][Full Text] [Related]
79. Adult acral cutaneous myofibromas in a patient with generalized morphea. English JC; Derdeyn AS; Smith PD; Patterson JW J Am Acad Dermatol; 2002 Jun; 46(6):953-6. PubMed ID: 12063499 [TBL] [Abstract][Full Text] [Related]